Sensus Healthcare, Inc. Forecast, price target & analysts
Sensus Healthcare, Inc. Target price 2025 - Analyst rating & recommendation
Sensus Healthcare, Inc. Classifications & Recommendation:
Sensus Healthcare, Inc. Price Target
| Target Price | $13.00 |
| Price | $4.74 |
| Potential |
174.26%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Sensus Healthcare, Inc. 2026 .
The average Sensus Healthcare, Inc. target price is $13.00.
This is
174.26%
register free of charge
$18.00
279.75%
register free of charge
$10.00
110.97%
register free of charge
|
|
| A rating was issued by 5 analysts: 5 Analysts recommend Sensus Healthcare, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sensus Healthcare, Inc. stock has an average upside potential 2026 of
174.26%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 41.81 | 44.71 |
| 71.28% | 6.94% | |
| EBITDA Margin | 19.92% | 17.21% |
| 16,111.06% | 13.62% | |
| Net Margin | 16.18% | 15.22% |
| 697.90% | 5.94% |
5 Analysts have issued a sales forecast Sensus Healthcare, Inc. 2025 . The average Sensus Healthcare, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Sensus Healthcare, Inc. EBITDA forecast 2025. The average Sensus Healthcare, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Sensus Healthcare, Inc. Analysts have issued a net profit forecast 2025. The average Sensus Healthcare, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.41 | 0.41 |
| 1,266.67% | 0.00% | |
| P/E | 11.49 | |
| EV/Sales | 1.26 |
4 Analysts have issued a Sensus Healthcare, Inc. forecast for earnings per share. The average Sensus Healthcare, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Sensus Healthcare, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Sensus Healthcare, Inc....
Current Sensus Healthcare, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Feb 10 2025 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Nov 18 2024 |
| Maxim Group | Locked ➜ Locked | Locked | Nov 15 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Feb 10 2025 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Nov 18 2024 |
|
Locked
Maxim Group: Locked ➜ Locked
|
Nov 15 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
